Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub, your source for evidence-based coverage of GLP-1 therapies, weight management protocols, and the genetics underneath them. Browse all Peptides & GLP-1 education
This review is independent editorial. PlexusDx has no commercial relationship with LifeMD or its parent company, and no affiliate links or compensation are involved.
LifeMD is one of many telehealth programs competing in GLP-1 weight management. Rather than crown a winner, this review walks through how LifeMD's weight-loss program is built: the medication options, the eligibility gate, the fulfillment path, and the cost structure. Details reflect April 2026 and change often, so treat the brand's own site as the live reference.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Inside the LifeMD weight-loss program
LifeMD runs as subscription telehealth. In this model a patient completes a virtual clinical evaluation with a licensed provider, receives a written prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and continues with periodic follow-up. The exact menu of medications and support tiers is published on LifeMD's official website.
Who qualifies, and how intake works
Eligibility in telehealth GLP-1 programs is gated at intake. A prospective patient submits weight, medical history, and a current medication list; a licensed clinician reviews that information and, if the clinical criteria are met, issues a prescription. Not everyone qualifies, and honest intake matters because contraindications and drug interactions are screened here. Programs differ in whether a physician or a nurse practitioner or physician associate performs that review.
From prescription to your doorstep
Once a prescription is issued, it is routed to a pharmacy partner for fulfillment — a retail pharmacy for brand-name products or a licensed compounding pharmacy for compounded formulations. Ongoing telehealth follow-up then supports dose titration and side-effect management over the weeks that follow. The fulfillment route you land in depends on product availability, eligibility, and the specific plan you enroll in.
What you can expect to pay
LifeMD publishes its own pricing, and it moves over time. Total monthly spend depends on the product (semaglutide versus tirzepatide versus another option), the subscription tier, and whether you are dispensed FDA-approved brand medication or a compounded alternative. Across the telehealth GLP-1 market as of April 2026, monthly totals commonly range from roughly $200 to $700 and up. Confirm the current figure on the brand's site before committing.
The clinical evidence behind the compounds
A program's results rest on the compound it dispenses, not on the platform. The relevant class is GLP-1 receptor agonists — semaglutide, liraglutide, dulaglutide — plus the GIP/GLP-1 dual agonist tirzepatide. Landmark trials include STEP (semaglutide for weight management, published in The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Populations and endpoints differ across studies, and individual outcomes vary.
The upstream genetic factor LifeMD does not screen
An intake form captures weight, history, and medications, but no telehealth program of this kind screens the genetic architecture underneath your metabolism. Variants in FTO (the fat-mass and obesity-associated gene), MC4R (a melanocortin receptor central to satiety and energy balance), GLP1R (the receptor every GLP-1 compound targets), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the baseline terrain a GLP-1 protocol acts on. These pathway-level insights do not predict your response to any specific compound; they describe the biology your provider is prescribing into.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before you begin, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including the FTO, MC4R, TCF7L2 variants that shape your appetite-regulation and energy-balance biology. That is the test before you invest approach — pairing the protocol with genetic context so the conversation with your healthcare provider starts from data rather than guesswork.
Not affiliated: PlexusDx has no affiliation with LifeMD and no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: GLP 1 Receptor Agonist For Weight Loss, Monjiro For Weight Loss, Rybelsus Weight Loss, Victoza For Weight Loss.
Disclaimer: This article is educational. PlexusDx is not affiliated with LifeMD and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols, or start upstream and take the Precision Peptide Genetic Test to map your GLP-1 pathway first.
Frequently Asked Questions
Is LifeMD's weight-loss program legitimate?
LifeMD operates in the GLP-1 telehealth space as of April 2026. Legitimate programs share common traits: licensed clinicians, state-licensed pharmacy partners, clear pricing, and a clinical evaluation before any prescription is written. Verify licensure and credentialing on the brand's own site before making a purchase decision, since claims alone are not proof.
Who is eligible for LifeMD weight loss?
Eligibility is decided at intake, where a licensed clinician reviews your weight, medical history, and medications against clinical criteria. Not every applicant qualifies, and disclosing contraindications honestly matters for safety. Exact criteria vary by program and by the provider reviewing your case, so the intake outcome is individual to you.
How much does the LifeMD program cost?
Pricing is published on LifeMD's own site and changes over time. Monthly totals across telehealth GLP-1 programs generally fall between roughly $200 and $700 or more as of April 2026, depending on medication, subscription tier, and dispensing pathway. Confirm the current amount on the brand's site before you commit to a plan.
What does the Precision Peptide Genetic Test add to a program like LifeMD?
It adds upstream genetic context that intake forms skip. By reporting pathway-level variants in FTO and MC4R, the test describes your baseline metabolic biology. It does not predict response to any compound or rank telehealth programs, but it can make your provider conversation more specific before you enroll anywhere.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
LifeMD and Zepbound: Brand, Compounded, and the Molecule
LifeMD and Zepbound: Brand, Compounded, and the Molecule